Coronavirus: OPPI members reiterate commitment to address COVID-19 situation in India

By: |
March 16, 2020 4:46 PM

Established in 1965, OPPI represents the research-based pharmaceutical companies in India.

coronavirus, coronavirus outbreakFrom the outset of the epidemic, global research-based pharmaceutical companies have reviewed their drug and vaccine portfolios to see if there is any research that could be of help in addressing this epidemic

The Organisation of Pharmaceutical Producers of India (OPPI) on Monday reiterated support and commitment of its members towards working with the government in addressing the coronavirus situation by ensuring supply continuity of medicines.

“OPPI and its member companies reassure availability of adequate supplies of medicines for those in need of them,” the industry body said in a statement.

Currently, the member companies of OPPI have adequate inventory in India and efforts are being made to step up further production, it added.

“OPPI members are committed to working on measures to ensure that there are no shortages and that there is continuity in the pharmaceutical supply chain through a focused engagement with all critical stakeholders across the supply chain,” the statement said.

From the outset of the epidemic, global research-based pharmaceutical companies have reviewed their drug and vaccine portfolios to see if there is any research that could be of help in addressing this epidemic, it added.

“This analysis involved scientists assessing the companies’ libraries for potentially useful assets that could help with the development of new or repurposed treatments or vaccines to fight against the novel coronavirus,” the statement said.

Relevant assets include diagnostics and biomarkers, approved therapies or compounds in development which could be repurposed for use in treating patients with coronavirus, it added.

In addition, these companies are undertaking to identify any ACE inhibitors, protease inhibitors or immunotherapies that could be relevant in the context of coronavirus, OPPI said.

Established in 1965, OPPI represents the research-based pharmaceutical companies in India.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Covid-19: Legal wrangles hold up U.S. vaccine donations to India
2Delhi’s Pharma University nears landmark; Makes breakthrough Ayurvedic treatment for Covid-19
316 new Olympics-related COVID-19 cases, but no athlete and none from Games Village